As reported by the Boston Globe, e-mails and other internal company documents suggest that executives at Pfizer covered up a negative European study of the epilepsy drug Neurontin in order to bolster marketing efforts. Evidence of an effort to suppress publication of the study arose as part of a lawsuit currently pending in Boston. The documents also suggest that Pfizer based a large-scale marketing campaign on the results of a seemingly positive study.
We are committed to stopping such abusive practice by the pharmaceutical companies.For more information on our pharamceutical litigation practice, click HERE.
If you believe you have been injured from taking a prescription drug, please contact Ed Wallis today at (901) 527-2125, or send Ed an e-mail by clicking HERE.